Not applicableStudy completedNCT03233178
What this trial is testing
Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000